Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer

2 Views
administrator
administrator
09/30/23

Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next